参考文献/References:
[1] Jemal A, Murray T, Ward E, et al. Cancer statistics [J], 2005. CA: A Cancer J Clin, 2005. 55(1): 10-30.
[2] Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades [J]. J Urol, 2000, 164(5): 1523-1525.
[3] Jensen, OM, Knudsen JB, McLaughlin JK, et al. The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures[J]. Int J Cancer, 1988, 41(4): 557-561.
[4] Palvio, DH, Andersen JC, Falk E, et al. Transitional cell tumors of the renal pelvis and ureter associated with capillarosclerosis indicating analgesic abuse[J]. Cancer, 1987, 59(5): 972-976.
[5] McCarron JP, Mills C, Vaughn ED Jr. Tumors of the renal pelvis and ureter: current concepts and management [J]. Semin Urol, 1983, 1(1): 75-81.
[6] Zincke H, Neves RJ. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract [J]. Urol Clin North Am, 1984, 11(4): 717-724.
[7] Babaian RJ, Johnson DE, Primary carcinoma of the ureter [J]. J Urol, 1980, 123(3): 357-359.
[8] Lughezzani G, Jeldres C, Isbarn H, et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients [J]. Eur J Cancer, 2009, 45(18): 3291-3297.
[9] Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial carcinoma: current treatment and outcomes [J]. Urology, 2012, 79 (4): 749-756.
[10] Kondo T, Nakazawa H, Ito F, et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract[J]. Urology, 2007, 69(2): 265-269.
[11] Hisataki T, Miyao N, Masumori N, et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer[J]. Urology, 2000, 55(5): 663-667.
[12] Hafner C, Knuechel R, Stoehr R, et al. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies[J]. Int J Cancer, 2002, 101(1): 1-6.
[13] Takahashi T, Habuchi T, Kakehi Y,et al. Clonal and chronological ge netic analysis of multifocal cancers of the bladder and upper urinary tract[J]. Cancer Res, 1998, 58(24): 5835-5841.
[14] Hafner C, Knuechel R, Zanardo L, et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract [J]. Oncogene, 2001, 20(35): 4910-4915.
[15] Rai BP, Shelley M, Coles B, et al. Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review[J]. BJU Int, 2012, 110(10): 1426-1435.
[16] Lim SK, Shin TY, Kim KH, et al. Intermediate-term outcomes of robot-assisted laparoscopic nephroureterectomy in upper urinary tract urothelial carcinoma[J]. Clin Genitourin Cancer, 2013, 11(4): 515-521.
[17] Zou L, Zhang L, Zhang H, et al. Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma[J]. World J Urol, 2014, 32(2): 565-570
[18] Fairey AS, Kassouf W, Estey E, et al. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration [J]. BJU Int, 2013, 112(6): 791-797.
[19] Ariane MM, Colin P, Ouzzane A, et al. Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study[J]. Ann Surg Oncol, 2012, 19(1): 301-308.
[20] Walton TJ, Novara G, Matsumoto K, et al. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort[J]. BJU Int, 2011, 108(3): 406-412.
[21] Favaretto RL, Shariat SF, Chade DC, et al. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique [J]? Eur Urol, 2010, 58(5): 645-651.
[22] Simone G, Papalia R, Guaglianone S, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study [J]. Eur Urol, 2009, 56(3): 520-526.
[23] Greco F, Wagner S, Hoda RM, et al. Laparoscopic vs open radical nephroureterectomy for upper urinary tract urothelial cancer: oncological outcomes and 5-year follow-up[J]. BJU Int, 2009, 104 (9): 1274-1278.
[24] Waldert M, Remzi M, Klingler HC, et al. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy[J]. BJU Int, 2009, 103(1): 66-70.
[25] Rose K, Khan S, Godbole H, et al. Robotic assisted retroperitoneoscopic nephroureterectomy -- first experience and the hybrid port technique[J]. Int J Clin Pract, 2006, 60(1): 12-14.
[26] Eun D, Bhandari A, Boris R, et al. Concurrent upper and lower urinary tract robotic surgery: strategies for success [J]. BJU Int,2007, 100(5): 1121-1125.
[27] Trinh QD, Sammon J, Sun M, et al. Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample [J].Eur Urol, 2012, 61(4): 679-685.
[28] Iborra I, Solsona E, Casanova J, et al. Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression[J]. J Urol, 2003,169(1): 82-85.
[29] Jeldres C, Lughezzani G, Sun M, et al. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter[J]. J Urol, 2010, 183(4): 1324-1329.
[30] Colin P, Ouzzane A, Pignot G, et al. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study [J]. BJU Int,2012, 110(8): 1134-1141.
[31] Dalpiaz O, Ehrlich G, Quehenberger F, et al. Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter[J]. Urol Oncol, 2013, 32(1): 34.e1-34.e8
[32] Lucas SM, Svatek RS, Olgin G, et al. Conservative management in selected patients with upper tract urothelial carcinoma compares